FDA names former pharmaceutical company executive to oversee US drug program
FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency's Center for Drug Evaluation and Research, which regulates the safety and effectiveness of all U.S. drugs.
His appointment comes a month after the center's acting director, Dr. Jacqueline Corrigan-Curay, announced her retirement.
As the agency's top drug regulator, Tidmarsh will be charged with following through on a number of commitments made by Makary and his boss, Health Secretary Robert F. Kennedy Jr., including reviewing the safety of the abortion pill mifepristone. The FDA is also scrutinizing certain uses of other long-established drugs, including antidepressants and hormone-replacement drugs for menopause.
Tidmarsh founded and led several pharmaceutical companies, including Horizon Pharmaceuticals, maker of an anti-inflammatory medication for arthritis. He has also served as an adjunct professor at Stanford University.
The FDA's drug center is the agency's largest unit, with nearly 6,000 staffers responsible for reviewing the safety and effectiveness of new drugs and monitoring the use and marketing of older drugs.
About 2,000 FDA staffers have been laid off as part of widescale cuts to the federal health workforce overseen by Kennedy. More than 1,000 others have taken buyouts or early retirement, while many others are reportedly searching for new jobs. The departures have threatened basic FDA operations, including the timely review of new drugs.
Nearly all of the FDA's senior leadership positions have turned over in recent months, either due to retirements, resignations or actions by administration officials placing them on administrative leave.
FDA center directors typically hold their positions for years or even decades, serving across multiple administrations, whether Republican or Democrat.
In May, Makary named Dr. Vinay Prasad, a prominent critic of the FDA's COVID response, to run the agency's vaccine center. He was also named to the post of FDA chief medical officer. Prasad joined the agency after his predecessor, longtime vaccine chief Dr. Peter Marks, was forced out in March.
The head of FDA's tobacco center was also forced to step down in April. A permanent replacement has not yet been named.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
20 minutes ago
- The Hill
Most Americans support legal access to abortions in most cases: Survey
Most Americans still support legal abortions despite a wave of rollbacks following the Supreme Court's decision overturning the federal right to access the procedure over three years ago, a new survey shows. The AP-NORC Research Center poll, published Thursday, revealed that 64 percent of participants said abortion should be legal in all or most cases. About 27 percent of people said the procedure should be illegal in most cases and 9 percent said it should be illegal in all cases. The results were split along party lines. A majority of Democrats, 85 percent, and independents, 67 percent, said they believe abortion should be lawfully permitted in cases of medically terminated pregnancies and use of an abortion pill. On the opposite side, 15 percent of Democrats and 33 percent of independents disagreed, according to the survey. More than half, 58 percent, of Republicans said abortion should be illegal in all or most cases, while 41 percent of GOP respondents shared an opposite view. The poll also found that an overwhelming majority of respondents, regardless of their political party, said abortions should be allowed if the mother's health is at risk due to pregnancy or in the case of rape, incest or potential fetal abnormality. As states reflect on the impact of the 2022 Dobbs vs. Jackson Women's Health case — which overturned Roe v. Wade — the survey asked in which cases should medical abortions should be approved. Around 70 percent said abortions, which have increased since the landmark ruling, should be allowed in cases of maternal medical emergencies. A small majority, 56 percent, also said mothers should be permitted to travel to obtain an abortion in a different state if it's illegal where they reside. The AP-NORC poll was conducted from July 10-14 featuring 1,437 U.S. adults. The overall margin of error is plus or minus 3.6 percentage points.
Newsweek
an hour ago
- Newsweek
Target Recall Update Issued Nationwide: Customers Urged Not to Eat Products
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Several products stocked at Target stores nationwide have been recalled due to risks ranging from undeclared allergens to potential contamination with Listeria monocytogenes. YoCrunch Yogurts Several types of YoCrunch Yogurts have been recalled by the company due to the potential presence of plastic pieces in the dome topper, which could be a choking hazard if consumed, the Food and Drug Administration said. Out of the products stocked at Target, the affected types are the YoCrunch Low Fat Vanilla with OREO Yogurt, YoCrunch Low Fat Vanilla with M&Ms Yogurt, YoCrunch Low Fat Strawberry with M&Ms Yogurt, all in 4ct/4oz size cups. Also included are the YoCrunch Low Fat Vanilla with OREO and M&Ms Yogurt Variety Pack with 8ct/6oz size cups. The FDA said that the loose plastic pieces are only at risk of being found in the separately packaged topper, and this does not impact the separately packaged yogurt. It said that the transparent plastic pieces may have sharp edges and are between 7 and 25 mm in length. A Target shopping center storefront pictures on Oxon Hill, Maryland USA June 22, 2024. A Target shopping center storefront pictures on Oxon Hill, Maryland USA June 22, 2024. Getty Images Customers who have purchased the affected products are advised not to consume them, and can contact YoCrunch's consumer care department for information about refunds. The recall was initiated voluntarily by manufacturer Danone U.S. in cooperation with the FDA on July 11. Newsweek contacted Danone U.S. for comment via email on Thursday. RITZ Peanut Butter Cracker Sandwiches RITZ Peanut Butter Cracker Sandwiches have been recalled due to incorrect labeling that may not specify they contain peanuts. In several multi-pack varieties, some individual packs may be incorrectly labeled as the cheese variety even though it may be a peanut butter variety, the FDA notice said. All outer labels on cartons are correct. The recall notice said that the issue was a "supplier error" and that corrective actions are being taken to help ensure this issue does not recur. Out of the products stocked at Target, the recall applies to Ritz Cracker Sandwiches with Peanut Butter in the 8ct/11.04oz size, and Ritz Peanut Butter Cracker Sandwiches Family Size 27.6oz/20ct. Customers with peanut allergies are advised to not eat the products and to discard them. The manufacturer Mondelēz Global LLC announced the voluntary recall on July 8. Mondelēz confirmed that it was conducting a voluntary recall of products in an emailed statement to Newsweek and pointed to their press release for more information. Oscar Mayer Turkey Bacon Oscar Mayer Turkey Bacon in 12oz packages sold at Target are among Kraft Heinz products being recalled byb the company due to risks that they are contaminated with Listeria monocytogenes, the United States Department of Agriculture said. The recalled products have the USDA mark of inspection on them. A contamination was detected through lab testing, and no confirmed illnesses have been reported so far. Listeria infection, or listeriosis, can cause severe illness, especially in older adults, those with weakened immune systems, and pregnant women. Symptoms may include fever, muscle aches, and gastrointestinal issues, with more severe risks such as miscarriage and death for vulnerable groups. The USDA urges consumers not to eat the affected turkey bacon and to either discard it or return it to the store. Kraft Heinz told Newsweek in an emailed statement: "We are also working collaboratively with public health authorities, including the United States Department of Agriculture (USDA), to take the appropriate steps and initiate a recall. We deeply regret this situation and apologize to any consumers we have disappointed."
Miami Herald
an hour ago
- Miami Herald
A drug carrying the FDA's most serious warning recalled by a Florida company
A pharmaceutical company based in Naples with research and development division based in Coral Springs recalled a drug for failing an in-house testing of medication degradation. Lupin Pharmaceuticals' Clomipramine Hydrochloride capsules are used 'for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD),' according to the National Library of Medicine. The 2,724 recalled 100-count bottles of 25 mg capsules come from lot No. M300464 with an expiration date of June 2025. Lupin issued no press release for the June 27 recall. READ MORE: The role fake Viagra played in a 70-year-old Miami doctor losing his license Clomipramine also counts as an antidepressant and carries an FDA 'Black Box Warning' or 'Boxed Warning' on the packaging that begins: 'Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders. Anyone considering the use of clomipramine hydrochloride or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need.' If you experience a medical problem because of this or any other drug, first notify a medical professional. Then tell the FDA via the MedWatch program, either online or by calling 800-332-1088.
